Tradewinds Capital Management’s Maravai LifeSciences MRVI Stock Holding History

Tradewinds Capital Management’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-50	Closed	-$2K	–	782
2021 Q2	$2K	Hold	50	–	–	﹤0.01%	671
2021 Q1	$2K	Buy	+50	New	+$1.66K	﹤0.01%	639

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Tradewinds Capital Management's MRVI Position: Q3 2021 in Review

Tradewinds Capital Management sold out of Maravai LifeSciences (MRVI) in Q3 2021, closing a stake of 50 shares — an estimated $2K sold.

Tradewinds Capital Management first reported a position in MRVI in Q1 2021 and held it in 2 quarters. The position peaked at $2K in Q2 2021. 228 funds tracked by Wall St. Rank hold MRVI as of Q3 2021.

Tradewinds Capital Management reported no remaining Maravai LifeSciences position as of Q3 2021 after selling out during the quarter.
Tradewinds Capital Management sold 50 Maravai LifeSciences shares in Q3 2021, an estimated $2K.
Tradewinds Capital Management first reported a position in Maravai LifeSciences in Q1 2021 and held it in 2 quarters.
Tradewinds Capital Management's Maravai LifeSciences position peaked at $2K in Q2 2021.
228 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q3 2021.

Based on Tradewinds Capital Management's 13F filing for Q3 2021, filed 4 Nov 2021.